Success of posaconazole therapy in a heart transplanted patient with Alternaria infectoria cutaneous infection

8Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cutaneous Alternaria spp. infections occur mainly in immunosuppressed patients and itraconazole is considered as the drug of choice. We report the case of a 64-year-old heart transplanted female patient with multiple cutaneous lesions caused by Alternaria infectoria. Treatment with posaconazole resulted in complete recovery. Due to lower minimal inhibitory concentrations, better distribution and less drug interactions than with itraconazole, posaconazole may become the antifungal drug to consider in the management of cutaneous infections caused by Alternaria spp. in solid organ transplant recipients. © 2012 ISHAM.

Cite

CITATION STYLE

APA

Rammaert, B., Aguilar, C., Bougnoux, M. E., Noël, N., Charlier, C., Denis, B., … Lortholary, O. (2012). Success of posaconazole therapy in a heart transplanted patient with Alternaria infectoria cutaneous infection. Medical Mycology, 50(5), 518–521. https://doi.org/10.3109/13693786.2011.641165

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free